16. April 2021
Global Data Hub – 8 von 17 Insights
Since our last feature on data exports in October 2020, we've seen significant developments including the EU's new draft standard contractual clauses, draft UK adequacy agreements and guidance on applying the Schrems II judgment. We also look at the impact of data export rules on clinical trial data, data exports from Asia, and data transfers in the context of M&A deals.
Paul Voigt looks at the pros and cons of the new draft SCCs.
Vin Bange and Jo Joyce look at the development of data transfer laws in Asia, focusing on six major jurisdictions.
Tamara Mackay-Temesy looks at data transfers and other issues in the context of M&A deals.
Debbie Heywood looks at the draft UK adequacy decisions published by the EC and what they mean for future EU-UK data exports.
Debbie Heywood looks at the EDPB recommendations on supplementing data transfer tools to help protect personal data exported to third countries.
Debbie Heywood looks at cross-border transfers of clinical trial data in the UK and the EU.
von Helen Farr
von mehreren Autoren
von mehreren Autoren
von Debbie Heywood
von Debbie Heywood
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von Debbie Heywood
von Debbie Heywood
von Debbie Heywood